SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-154012
Filing Date
2021-12-28
Accepted
2021-12-28 19:04:16
Documents
1
Period of Report
2021-12-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2136401-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2136401-1_4seq1.xml 4 3097
  Complete submission text file 0001104659-21-154012.txt   4552
Mailing Address 633 LOWTHER ROAD LEWISBERRY PA 17339
Business Address
Naftzger J. Christopher (Reporting) CIK: 0001496194 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 211525937

Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations